D.W. Moreland

693 total citations
22 papers, 534 citations indexed

About

D.W. Moreland is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, D.W. Moreland has authored 22 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in D.W. Moreland's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (5 papers) and RNA and protein synthesis mechanisms (3 papers). D.W. Moreland is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (5 papers) and RNA and protein synthesis mechanisms (3 papers). D.W. Moreland collaborates with scholars based in United States, Belarus and Canada. D.W. Moreland's co-authors include Houng‐Yau Mei, David P. Mack, Adam Galan, Anthony W. Czarnik, Roy D. Schwarz, Christine Humblet, James B. Dunbar, William G. Dauben, Juan C. Jaén and Andrea Heldsinger and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

D.W. Moreland

21 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.W. Moreland United States 11 374 81 69 66 53 22 534
Earl Rutenber United States 12 743 2.0× 132 1.6× 85 1.2× 62 0.9× 22 0.4× 14 1.4k
Stéphane Boivin France 14 468 1.3× 43 0.5× 22 0.3× 36 0.5× 36 0.7× 27 894
Somsak Pianwanit Thailand 14 340 0.9× 57 0.7× 70 1.0× 65 1.0× 18 0.3× 44 570
Gaël Coadou France 14 249 0.7× 110 1.4× 21 0.3× 13 0.2× 55 1.0× 29 509
Kenta Teruya Japan 17 748 2.0× 151 1.9× 139 2.0× 31 0.5× 39 0.7× 61 997
Sandriyana Soelaiman United States 8 639 1.7× 10 0.1× 38 0.6× 37 0.6× 24 0.5× 8 778
Robert D. Malmstrom United States 11 427 1.1× 33 0.4× 149 2.2× 25 0.4× 70 1.3× 17 636
Ruth Barak Israel 9 218 0.6× 54 0.7× 36 0.5× 11 0.2× 29 0.5× 11 485
Maria J. P. van Dongen Netherlands 11 359 1.0× 46 0.6× 32 0.5× 27 0.4× 29 0.5× 14 462
Joël Pothier France 14 440 1.2× 23 0.3× 43 0.6× 21 0.3× 35 0.7× 29 586

Countries citing papers authored by D.W. Moreland

Since Specialization
Citations

This map shows the geographic impact of D.W. Moreland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W. Moreland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W. Moreland more than expected).

Fields of papers citing papers by D.W. Moreland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.W. Moreland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W. Moreland. The network helps show where D.W. Moreland may publish in the future.

Co-authorship network of co-authors of D.W. Moreland

This figure shows the co-authorship network connecting the top 25 collaborators of D.W. Moreland. A scholar is included among the top collaborators of D.W. Moreland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.W. Moreland. D.W. Moreland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pontelli, Enrico, et al.. (2009). BIOPS Interactive: An e-Learning Platform Focused on Protein Structure and DNA. 35(2). 6–15. 1 indexed citations
2.
Beckman, Robert A., D.W. Moreland, Shirley Louise‐May, & Christine Humblet. (2006). RNA unrestrained molecular dynamics ensemble improves agreement with experimental NMR data compared to single static structure: a test case. Journal of Computer-Aided Molecular Design. 20(5). 263–279. 2 indexed citations
3.
Dunn, John R., James E. Keen, D.W. Moreland, & R. Alex Thompson. (2004). Prevalence of Escherichia coli O157:H7 in White-tailed Deer from Louisiana. Journal of Wildlife Diseases. 40(2). 361–365. 44 indexed citations
4.
Tecle, Haile, Roy D. Schwarz, Stephen D. Barrett, et al.. (2000). CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology. Pharmaceutica Acta Helvetiae. 74(2-3). 141–148. 11 indexed citations
5.
Augelli‐Szafran, Corinne E., C. John Blankley, Juan C. Jaén, et al.. (1999). Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists. Journal of Medicinal Chemistry. 42(3). 356–363. 11 indexed citations
6.
Augelli‐Szafran, Corinne E., et al.. (1998). Identification and characterization of m4 selective muscarinic antagonists. Bioorganic & Medicinal Chemistry Letters. 8(15). 1991–1996. 35 indexed citations
7.
Augelli‐Szafran, Corinne E., et al.. (1998). ChemInform Abstract: Identification and Characterization of m4 Selective Muscarinic Antagonists.. ChemInform. 29(47). 1 indexed citations
8.
Mei, Houng‐Yau, David P. Mack, Adam Galan, et al.. (1997). Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorganic & Medicinal Chemistry. 5(6). 1173–1184. 121 indexed citations
9.
Augelli‐Szafran, Corinne E., et al.. (1997). Identification and characterization of m4 selective muscarinic antagonists. Life Sciences. 60(13-14). 1168–1168. 2 indexed citations
10.
Dunbar, James B., et al.. (1995). Enhancing the diversity of a corporate database using chemical database clustering and analysis. Journal of Computer-Aided Molecular Design. 9(5). 407–416. 75 indexed citations
11.
Schwarz, Roy D., Juan C. Jaén, Tara Mirzadegan, et al.. (1995). Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists. Life Sciences. 56(11-12). 923–929. 13 indexed citations
12.
Jaén, Juan C., Stephen D. Barrett, Mark R. Brann, et al.. (1995). In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832. Life Sciences. 56(11-12). 845–852. 18 indexed citations
13.
Mei, Houng‐Yau, et al.. (1995). Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics. Bioorganic & Medicinal Chemistry Letters. 5(22). 2755–2760. 121 indexed citations
14.
Tecle, Haile, Robert E. Davis, Tara Mirzadegan, et al.. (1995). (±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 5(6). 637–642. 4 indexed citations
16.
Tecle, Haile, Tara Mirzadegan, Walter H. Moos, et al.. (1993). Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists. Life Sciences. 52(5-6). 505–511. 18 indexed citations
17.
Moreland, D.W.. (1993). A model for ligand binding at the muscarinic cholinergic receptor. Life Sciences. 52(5-6). 559–559. 1 indexed citations
18.
Tecle, Haile, Tara Mirzadegan, Walter H. Moos, et al.. (1992). A rationale for the design and synthesis of m1 selective muscarinic agonists.. Bioorganic & Medicinal Chemistry Letters. 2(8). 821–826. 10 indexed citations
19.
Davidson, William R., et al.. (1989). FEATHER DAMAGE DUE TO MYCOTIC INFECTIONS IN WILD TURKEYS. Journal of Wildlife Diseases. 25(4). 534–539. 9 indexed citations
20.
Moreland, D.W. & William G. Dauben. (1985). Transition-state modeling in acyclic stereoselection. A molecular mechanics model for the kinetic formation of lithium enolates. Journal of the American Chemical Society. 107(8). 2264–2273. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026